Long-Term Multicenter Evaluation of the E1® Tibial Bearing

NCT01374230 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2018-07-30

No results posted yet for this study

Summary

This study has been designed to document the long-term outcome of the E1® Tibial Bearings used with the Vanguard® Knee System in 500 patients receiving total knee arthroplasty. All patients will receive the E1® Tibial Bearing in a Vanguard® knee replacement. Radiographic analysis and patient reported outcomes will be used as follow-up measures to track wear, mechanical performance, and patient satisfaction.

Conditions

  • Osteoarthritis of the Knee
  • Traumatic Arthritis of the Knee

Interventions

PROCEDURE

Total knee arthroplasty

Primary total knee arthroplasty surgery for the treatment of osteoarthritis.

Sponsors & Collaborators

  • Stanford University

    collaborator OTHER
  • Aalborg University Hospital

    collaborator OTHER
  • Göteborg University

    collaborator OTHER
  • Hospital Universitario La Paz

    collaborator OTHER
  • Hvidovre University Hospital

    collaborator OTHER
  • Seoul National University Hospital

    collaborator OTHER
  • Ulsan University Hospital

    collaborator OTHER
  • Sydney Private Hospital, Australia

    collaborator UNKNOWN
  • Kennedy Center at Ascension Mercy Hospital

    collaborator OTHER
  • Southern Joint Replacement Institute

    collaborator UNKNOWN
  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Charles Bragdon, PhD · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01374230 on ClinicalTrials.gov